NASDAQ:NUVA
Delisted

Nuvasive Stock News

etoro logo Buy NUVA
*Your capital is at risk
$39.75
+0 (+0%)
At Close: Nov 30, 2023
NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock?
SAN DIEGO, May 19, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrat
SAN DIEGO, May 10, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integra
NuVasive, Inc. (NUVA) CEO Chris Barry on Q1 2021 Results - Earnings Call Transcript
NuVasive (NUVA) delivered earnings and revenue surprises of 12.12% and 3.88%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

NuVasive (NUVA) Enters Overbought Territory

09:02am, Tuesday, 04'th May 2021
NuVasive (NUVA) has moved higher as of late, but there could definitely be trouble on the horizon for this company
SAN DIEGO, May 3, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrat
Here are five orthopedic device stocks, Integra (IART), Conformis (CFMS), SeaSpine (SPNE), Zimmer Biomet (ZBH), Orthofix (OFIX), which are expected to continue their run over the next few months.
SAN DIEGO, April 19, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integ
NuVasive's (NUVA) Simplify Disc demonstrated an overall clinical success rate nearly 10% higher than the anterior cervical discectomy and fusion.
SAN DIEGO, March 25, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integ
NuVasive (NUVA) is optimistic about its strong international performance and a huge growth potential in the spine market.
NuVasive (NUVA) extends its long-term partnership with ISSGF and initiates additional clinical studies to transform the future of spine care.

NuVasive (NUVA) Enters Overbought Territory

07:35am, Wednesday, 17'th Mar 2021
NuVasive (NUVA) has moved higher as of late, but there could definitely be trouble on the horizon for this company
SAN DIEGO, March 16, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integ
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE